Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00038 | Doxorubicin hydrochloride | 25316-40-9 |
| Doxorubicin is an anthracycline antibiotic with antineoplastic activity produced by the bacterium Streptomyces peucetius var. Doxorubicin is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis. | Inquiry | |
| BADC-00041 | Daunorubicin hydrochloride | 23541-50-6 |
| Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM. | Inquiry | |
| BADC-00027 | INNO-206 | 1361644-26-9 |
| INNO-206 (Aldoxorubicin) is the 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. | Inquiry | |
| BADC-00028 | DOXO-EMCH | 151038-96-9 |
| DOXO-EMCH is an albumin-binding prodrug of doxorubicin, which is an anthracycline antibiotic with anti-Gram-positive bacterial activity and a broad antitumor spectrum. | Inquiry | |
| BADC-00042 | Doxorubicin EP Impurity A (Daunorubicin) | 20830-81-3 |
| Daunomycin is an anthracycline antibiotic produced by Streptomyces peucetius. The mechanism of action is the same as that of doxorubicin, which is inserted into DNA and inhibits RNA and DNA synthesis. It is mainly used for the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. It has anti-gram-positive bacteria, negative bacteria and tumor activity. | Inquiry | |
| BADC-00363 | Aldoxorubicin hydrochloride | 480998-12-7 |
| Aldoxorubicin is a prodrug of doxorubicin that binds to serum albumin immediately after administration through an acid-sensitive hydrazone linker and is subsequently transported to tumor tissues where the acidic environment cleaves the linker and facilitates delivery of a tumor-targeted drug payload. | Inquiry | |
| BADC-00685 | MCC-Modified Daunorubicinol | 721945-30-8 |
| Daunorubicinol is a drug-linker conjugate for ADC with potent antitumor activity by using Aur0101 (DNA Topoisomerase II inhibitor), linked via the ADC linker. | Inquiry | |
| BADC-01357 | PNU-159682 carboxylic acid | 1204819-92-0 |
| PNU-159682 carboxylic acid (compound 53) is a potent ADC cytotoxin encoding a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. PNU-159682 carboxylic acid is involved in protein folding and diverse functions such as cell adhesion, cell signaling, glycoprotein turnover, and roles in inflammation and immune responses. | Inquiry | |
| BADC-01358 | DMEA-PNU-159682 | 1799421-48-9 |
| DMEA-PNU-159682 (molecule D12) is an ADC cytotoxic molecule consisting of neomycin metabolite (MMDX) from liver microsomes and the potent ADC cytotoxin PNU-159682. | Inquiry | |
| BADC-01360 | Daunorubicin citrate | 1884557-85-0 |
| Daunorubicin citrate is a topoisomerase II inhibitor that intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair RNA and protein synthesis. It is used to treat cancer. | Inquiry | |
| BADC-01462 | N3-PEG4-DYKDDDD-Doxorubicin | |
| N3-PEG4-DYKDDDD-Doxorubicin is part of an antibody drug conjugate consisting of the anthracycline antibiotic Doxorubicin and a degradable ADC linker N3-PEG4-DYKDDDD. | Inquiry | |
| BADC-01463 | Azide-PEG4-VC-PAB-Doxorubicin | |
| Azide-PEG4-VC-PAB-Doxorubicin is composed of linker Azide-PEG4-VC-PAB and toxic molecule Doxorubicin, which can be used to prepare antibody-conjugated drugs. | Inquiry | |
| BADC-01464 | N3-PEG4-YPYDVPDYA-Doxorubicin | |
| N3-PEG4-YPYDVPDYA-Doxorubicin is part of an antibody drug conjugate consisting of the anthracycline antibiotic Doxorubicin and the degradable ADC linker N3-PEG4-YPYDVPDYA. | Inquiry |
